Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jan 13 2020

Full Issue

Republicans May Be Stuck Between Rock And Hard Place On Voting For Democrats' Drug Pricing Proposals

Senate Majority Leader Mitch McConnell has been hesitant to take up votes on House Democrats' drug pricing legislation, trying to protect his members from going on record against a bill that could help lower costs. But doing nothing is politically fraught with the issue at the front of many voters' minds.

The Hill: Drug Price Outrage Threatens To Be Liability For GOP

The GOP’s reluctance to challenge rising prescription drug costs could be a political liability for the party in 2020. Outrage over increasing prices has propelled the issue to the top of voters’ minds heading into the November elections, when Republicans hope to keep control of the Senate and retake the House. But proposals that would limit what drug companies can charge for their products face opposition from Republicans, presenting an obstacle to congressional passage. (Hellmann, 1/10)

Meanwhile —

The Hill: Democratic Groups Launch Ad Campaign Attacking Trump, GOP On Drug Pricing

A new advertising campaign spearheaded by Democratic strategists aims to excoriate congressional Republicans and the Trump administration for opposing Speaker Nancy Pelosi’s (D-Calif.) drug pricing legislation. The Patients Over Pharma campaign is run by Accountable.US, an umbrella organization of progressive watchdog groups that attacks the Trump administration’s apparent conflicts of interest and ties to industry groups. (Weixel, 1/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF